NERVGEN PHARMA CORP. Proceeds From Government Grants Classified As Financing Activities
NERVGEN PHARMA CORP. (NGEN) reported Proceeds From Government Grants Classified As Financing Activities of CAD 3.40 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities · last filed 2026-03-31
CAD
| Period end | Proceeds From Government Grants Classified As Financing Activities 1 month | Proceeds From Government Grants Classified As Financing Activities 12 month |
|---|---|---|
| 2025-12-31 | 3.40M CAD 40-F · filed 2026-03-31 | |
| 2023-06-30 | 4.22M CAD 40-F · filed 2026-03-31 |
USD
| Period end | Proceeds From Government Grants Classified As Financing Activities 1 month | Proceeds From Government Grants Classified As Financing Activities 12 month |
|---|---|---|
| 2025-12-31 | $2.56M 40-F · filed 2026-03-31 | |
| 2023-06-30 | $3.18M 40-F · filed 2026-03-31 |